Abstract Purpose The purpose of this study is to assess the utility of dual reader interpretation of prostate MRI in the evaluation/detection of prostate cancer, using the PI-RADS v2.1 scoring system.Methods We performed a retrospective study to assess the utility of dual reader interpretation for prostate MRI. All MRI cases compiled for analysis were accompanied with prostate biopsy pathology reports that included Gleason scores to correlate to the MRI PI-RADS v2.1 score, tissue findings and location of pathology within the prostate gland. To assess for dual reader utility, two fellowship trained abdominal imagers (each with?>?5?years of experience) provided independent and concurrent PI-RADS v2.1 scores on all included MRI examinations, which were then compared to the biopsy proven Gleason scores.Results After application of inclusion criteria, 131 cases were used for analysis. The mean age of the cohort was 63.6?years. Sensitivity, specificity and positive/negative predictive values were calculated for each reader and concurrent scores. Reader 1 demonstrated 71.43 sensitivity, 85.39 specificity, 69.77 PPV and 86.36 NPV. Reader 2 demonstrated 83.33 sensitivity, 78.65 specificity, 64.81 PPV and 90.91 NPV. Concurrent reads demonstrated 78.57 sensitivity, 80.9 specificity, 66 PPV and 88.89 NPV. There was no statistically significant difference between the individual readers or concurrent reads (p?=?0.79).Conclusion Our results highlight that dual reader interpretation in prostate MRI is not needed to detect clinically relevant tumor and that radiologists with experience and training in prostate MRI interpretation establish acceptable sensitivity and specificity marks on PI-RADS v2.1 assessment.
展开▼
